Navigation Links
GW Pharmaceuticals plc Reports 2013 Q4 and Full Year Financial Results
Date:11/19/2013

derived cannabinoid therapeutics and has a deep pipeline of additional clinical-stage cannabinoid product candidates targeting epilepsy (including an orphan pediatric epilepsy program), type 2 diabetes, ulcerative colitis, glioma and schizophrenia. For further information, please visit www.gwpharm.com.

Forward-looking statementsThis news release may contain forward-looking statements that reflect GWs current expectations regarding future events, including statements regarding financial performance, timing of clinical trials and data, relevance of GW products commercially available and in development, size of market opportunities, and development and regulatory clearance of GW's products. Forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including (inter alia), the success of the GW's research strategies, the applicability of the discoveries made therein, the successful and timely completion of uncertainties related to the regulatory process, and the acceptance of Sativex® and other products by consumer and medical professionals. A further list and description of risks, uncertainties and other risks associated with an investment in GW can be found in GW's filings with the U.S. Securities and Exchange Commission, including the prospectus related to the NASDAQ offering filed by GW with the SEC on May 1, 2013. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. GW undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. GW Pharmaceuticals plc

Consolidated income statement

For the year ended 30 September 2013Year endedYear endedYear ended30 Septemb
'/>"/>

SOURCE GW Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the ... sponsored by Mission Pharmacal Company. The survey, conducted by ... support community, revealed that 74 percent of osteoporosis patients ... form other than a pill or a tablet. ...
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2
... MabVax Therapeutics Inc., a privately held clinical stage ... based therapies to address the unmet medical need of preventing ... in a Phase II clinical trial aimed at assessing the ... the recurrence of sarcoma. The clinical trial will enroll 126 ...
... NEW YORK , July 22 Reportlinker.com announces that a new market ... , , ... , http://www.reportlinker.com/p0240598/Wireless-Medical-Technologies-2007-2010.html ... Wireless Medical Technologies work on the basis of ...
Cached Medicine Technology:MabVax Therapeutics Initiates Phase II Clinical Trial of Vaccine to Prevent Recurrent Sarcoma 2MabVax Therapeutics Initiates Phase II Clinical Trial of Vaccine to Prevent Recurrent Sarcoma 3Reportlinker Adds Wireless Medical Technologies 2007-2010 2Reportlinker Adds Wireless Medical Technologies 2007-2010 3Reportlinker Adds Wireless Medical Technologies 2007-2010 4
(Date:4/23/2014)... Ind. - Purdue University researchers have developed a way ... cell by using tiny gold particles with tails of ... of agricultural and biological engineering, used gold nanoparticles to ... as BRCA1 messenger RNA splice variants, which can indicate ... of these mRNA splice variants in a cell can ...
(Date:4/23/2014)... April 23, 2014Men whose testosterone falls below normal levels ... be overweight and have heart disease and type 2 ... testosterone-deficient men for further testing and possible treatment is ... Health , a peer-reviewed publication from Mary Ann Liebert, ... Journal of Men,s Health website at ...
(Date:4/23/2014)... of probiotics, antioxidants and other nutritional compounds, more and ... is getting in on the action. But legitimate skepticism ... industry is responding with clinical research to shore up ... Chemical & Engineering News (C&EN), the weekly news ... Bomgardner, a senior editor at C&EN, writes that about ...
(Date:4/23/2014)... researcher from the Cancer Science Institute of Singapore (CSI ... the cancer specific stem cell which causes gastric cancer. ... drugs for the treatment of this disease and other ... Dr Chan Shing Leng, Research Assistant Professor at CSI ... variant of a cell surface protein, CD44v8-10, marks gastric ...
(Date:4/23/2014)... prevent the depletion of self-control, according to research published ... Association for Psychological Science. , Self-control can be difficult ... attention on a boring textbook are hard things to ... difficulty: Exerting self-control for a long period seems to ... tasks. , "It is as if self-control is a ...
Breaking Medicine News(10 mins):Health News:Gold nanoparticles help target, quantify breast cancer segments in a living cell 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:ADHD drug may help preserve our self-control resources 2
... Industry-funded studies of breast cancer therapies are more ... studies//, researchers from the University of North Carolina ... Institute have found. In addition, significant differences exist ... supported by the pharmaceutical industry compared to trials ...
... serious turn with the involvement of social services in the case ... overweight, above three times the average for his age. ... diet does not undergo a sea change. He holds a record ... ,Connor’s mother and grandmother are expected to attend ...
... Ontario: Health Minister George Smitherman is tongue tied when ... for the working poor in Ontario. ... a Chief Dentist in Toronto, with a proposal to ... centers; The Minister has not given an answer to ...
... the Scottish Regional Treatment Centre at Stracathro Hospital, Angus on ... that are being extended to NHS patients. ,According ... to wait and they are being treated faster. This facility ... setup. ,Though there was some kind ...
... from a south Kolkata neighbourhood tested positive for the chikungunya ... symptoms of the disease after a few days, according to ... Prince Ghulam Mohammad Shah Road in the Lake Gardens area ... Women and Child Care Centre on Feb 19 complaining of ...
... woman in Orissa suspected of having contracted AIDS was allegedly ... ,Sabita Behera, 30, a resident of Keutunga village in ... the in-laws suspected she was an AIDS patient, police officer ... incident took place Friday night but came to light only ...
Cached Medicine News:Health News:Industry-funded Breast Cancer Trials More Likely to Yield Positive Results 2Health News:Grossly Overweight Boy Likely to Be Sent into Care 2
... utilizes a hot air drying device for polyacrylamide ... clear cellophane support for easy viewing. The assembly ... assembly surface for the drying frame. The dryer ... This 115 V, 60 Hz system includes a ...
... dryer is an electrophoresis gel vacuum dryer that ... dries these gels onto cellophane or filter paper ... elements which heat gels from above. The drying ... V unit includes power cord, porous gel support, ...
... supply is the latest edition ... offering. It sets new standards ... This product has unique features ... as microAmp detector, display and ...
... The 1000-90 is the most versatile power ... up to 1000 volts or 1250 milliamps ... competition. No other 1000 volt power supply ... for large protein gels or small focusing ...
Medicine Products: